Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

We investigated whether treatment with LDE-paclitaxel changes plaque progression by coronary CT angiography and is safe in patients with chronic coronary artery disease. Analysis of inflammatory biomarkers and coronary CTA was also performed at baseline and 4 weeks after treatment.

Coronary Artery Disease 59

Coronary Artery Disease Laboratory Plaque Biomarkers 59

Frontiers in Cardiovascular Medicine

FEBRUARY 12, 2024

Introduction Coronary artery disease (CAD) is a highly heritable and multifactorial disease. Numerous genome-wide association studies (GWAS) facilitated the construction of polygenic risk scores (PRS) for predicting future incidence of CAD, however, exclusively in European populations.

Coronary Artery Disease 59

Coronary Artery Disease Risk Factors Cholesterol Myocardial Infarction 59

DAIC

MAY 14, 2024

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

Heart BMJ

JANUARY 10, 2024

Myocardial infarction with non-obstructive coronary arteries (MINOCA) defines a heterogeneous group of atherosclerotic and non-atherosclerotic conditions, causing myocardial injury in the absence of obstructive coronary artery disease.

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Disease Ultrasound Plaque 40

American College of Cardiology

JULY 10, 2024

What is the outcome of contemporary revascularization strategies in patients presenting with myocardial infarction (MI) and multivessel coronary artery disease (CAD)?

Coronary Artery Disease 63

Coronary Artery Disease Myocardial Infarction Outcomes Article 63

The New England Journal of Medicine

APRIL 6, 2024

The benefit of beta-blockers after myocardial infarction was established before the advent of reperfusion and percutaneous coronary intervention and the availability of effective secondary preventive medications.1-3

Myocardial Infarction 73

Myocardial Infarction Coronary Artery Disease 73

Heart BMJ

JANUARY 29, 2024

Objectives To develop a tool including exercise electrocardiography (ExECG) for patient-specific clinical likelihood estimation of patients with suspected obstructive coronary artery disease (CAD). In the CAD validation cohort, obstructive CAD was defined as >50% diameter stenosis on invasive coronary angiography.

Coronary Artery Disease 40

Coronary Artery Disease Exercise Myocardial Infarction Risk Factors 40

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundCoronary computed tomography angiography is increasingly used as the first‐line test for suspected coronary artery disease. The overall mortality, cardiac deaths, myocardial infarctions, and hospitalizations for unstable angina were acquired from national registry data for 1 to 10 years of follow‐up (median, 4 years).

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Angina Hospital 40

Med Page Today

APRIL 10, 2024

(MedPage Today) -- ATLANTA -- Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in better outcomes compared.

Coronary Artery Disease 64

Coronary Artery Disease Myocardial Infarction Outcomes STEMI 64

American College of Cardiology

MAY 24, 2024

The goal of the FIRE trial was to evaluate multivessel revascularization guided by coronary physiology compared with culprit-only revascularization among elderly patients with acute myocardial infarction (MI) and multivessel coronary artery disease (CAD).

Coronary Artery Disease 60

Coronary Artery Disease Myocardial Infarction Physiology Article 60

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. Methods Data from the 2020 California State Inpatient Database was used retrospectively.

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

Coronary Artery Disease Journal

OCTOBER 30, 2023

Introduction Elevated peak cardiac troponin levels have been linked with increased morbidity and mortality in patients with acute myocardial infarction (AMI). Immature Platelets are young and relatively large platelets that are hyper-reactive and pro-thrombotic compared to regular platelets.

Myocardial Infarction 52

Myocardial Infarction STEMI 52

Med Page Today

APRIL 8, 2024

(MedPage Today) -- ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other cardiovascular risk factors, the.

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction Risk Factors Outcomes 52

Circulation: Cardiovascular Imaging

NOVEMBER 30, 2023

Circulation: Cardiovascular Imaging, Ahead of Print.

Coronary Artery Disease 72

Coronary Artery Disease Myocardial Infarction Cardiovascular Imaging Embolism 72

Nature Reviews - Cardiology

MAY 6, 2024

Nature Reviews Cardiology, Published online: 07 May 2024; doi:10.1038/s41569-024-01014-0 In 1993, Lincoff and Topol claimed that the thrombolytic treatment of ST-segment elevation myocardial infarction was suboptimal in many patients and gave an ‘illusion of reperfusion’.

Coronary Artery Disease 62

Coronary Artery Disease Myocardial Infarction Article Outcomes 62

Stroke Journal

FEBRUARY 1, 2024

Introduction:Cervical artery dissection (CAD) and acute ischemic stroke (AIS) are key health challenges. We utilized a multi-state database to examine myocardial infarction (MI) risk post stroke or CAD to estimate cardiovascular complication risk.Method:We analyzed State Inpatient Database from New York (2011-2017) and Florida (2011-2019).

Myocardial Infarction 40

Myocardial Infarction Inpatient Stroke Strokes 40

Coronary Artery Disease Journal

MARCH 27, 2024

No abstract available

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction 40

American College of Cardiology

APRIL 7, 2024

Long-term treatment with beta-blockers may not lower the risk of death or myocardial infarction (MI) in patients with MI, a preserved left ventricular ejection fraction (LVEF) of ≥50% and coronary artery disease, according to the results of the REDUCE-AMI study, presented during a Late-Breaking Clinical Trial session at ACC.24

Coronary Artery Disease 65

Coronary Artery Disease Myocardial Infarction Article 65

Open Heart

AUGUST 21, 2023

Background Insights on the differences in clinical outcomes, quality of life (QoL) and health resource utilisation (HRU) with different levels of care available to post-acute myocardial infarction (AMI) populations in rural and urban settings are limited.

Myocardial Infarction 52

Myocardial Infarction Angina Coronary Artery Disease Outcomes 52

Stroke Journal

FEBRUARY 1, 2024

0.81), P>0.001), myocardial infarction by 40% (OR, 0.60 (95%CI: 0.44-0.84), 0.84), P>0.001), new acute coronary syndrome by 53% (OR, 0.47(95%CI: Colchicine as a potential anti-inflammatory treatment among such patients has attracted much attention in recent years. 0.78), P>0.001) compared with control.

Coronary Artery Disease 40

Coronary Artery Disease Stroke Strokes Myocardial Infarction 40

European Journal of Heart Failure

OCTOBER 5, 2023

In this study, two independent cohorts were used to investigate for cardiovascular magnetic resonance (CMR) and genetic features of dilated cardiomyopathy (DCM) in individuals with coronary artery disease (CAD). Methods and results This study includes two cohorts.

Coronary Artery Disease 40

Coronary Artery Disease Cardiomyopathy Outcomes Myocardial Infarction 40

Open Heart

OCTOBER 27, 2023

Percutaneous coronary intervention (PCI) is widely adopted to treat chronic coronary artery disease. Numerous randomised trials have been conducted to test whether PCI may provide any prognostic advantage over oral medical therapy (OMT) alone, without definitive results.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Outcomes 52

Open Heart

JUNE 21, 2022

Background Several studies have demonstrated that complete revascularisation improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease. However, the optimal timing of non-culprit lesion revascularisation remains controversial.

Myocardial Infarction 52

Myocardial Infarction STEMI Coronary Artery Disease Outcomes 52

Coronary Artery Disease Journal

JANUARY 11, 2024

Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) covers an expanding group of patients over recent years. Previous studies showed considerable risks of outcomes in this group. However, there is a lack of evidence in young patients with MINOCA.

Myocardial Infarction 40

Myocardial Infarction Outcomes Atrial Fibrillation Risk Factors 40

CardiacWire

MAY 10, 2024

A study in the Journal of Vascular Surgery revealed that adding FFRCT assessments to patient workups prior to peripheral artery disease surgeries has a massive impact on coronary artery disease detection, treatments, and long-term outcomes.

Coronary Artery Disease 59

Coronary Artery Disease Peripheral Arterial Disease Ischemia Myocardial Infarction 59

Dr. Paddy Barrett

APRIL 5, 2024

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

Heart Disease 98

Heart Disease Coronary Artery Disease Heart Attack Heart attacks 98

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Myocardial Infarction Ischemia 111

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2024

Background Kounis syndrome is an acute coronary syndrome (ACS) caused by allergic reactions, including coronary artery spasm (type I) caused by allergies without coronary predisposing factors, pre-existing coronary atherosclerosis, and coronary artery disease.

Coronary Artery Disease 64

Coronary Artery Disease Electrocardiogram Myocardial Infarction Thrombosis 64

Open Heart

AUGUST 25, 2024

All the patients underwent NISI (involving myocardial perfusion imaging/stress echocardiography). The primary endpoints included cardiac death, non-fatal myocardial infarction and unplanned coronary revascularisation. Methods We prospectively included 1384 patients with LRHSs between March 2019 and March 2021.

Chest Pain 52

Chest Pain Coronary Artery Disease Myocardial Infarction Electrocardiogram 52

Cardiology Update

MARCH 25, 2024

Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. However, the comparative long-term efficacy of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with these conditions remains unclear.

Diabetes 122

Diabetes Coronary Artery Bypass Graft Outcomes Coronary Artery Disease 122

Coronary Artery Disease Journal

APRIL 24, 2024

Purpose Construction of a prediction model to predict the risk of major adverse cardiovascular events (MACE) in the long term after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI).

Myocardial Infarction 40

Myocardial Infarction STEMI Diabetes Hypertension 40

Coronary Artery Disease Journal

MARCH 7, 2024

Background Untreated multivessel disease (MVD) in acute myocardial infarction (AMI) has been linked to a higher risk of recurrent ischemia and death within one year.

Myocardial Infarction 40

Myocardial Infarction Ischemia Thrombosis Stents 40

Open Heart

JUNE 5, 2024

We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. Patients with coronary artery disease were excluded. vs 3.9%, p<0.001) and ST-elevation myocardial infarction (59.1% vs 9.9%, p=0.029).

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

This study describes the changes in cognitive function associated with coronary artery disease, myocardial infarction, heart failure, atrial fibrillation and heart valve disease. An updated understanding of the two known pathogenic mechanisms of cardiogenic dementia is presented and discussed.

Dementia 64

Dementia Coronary Artery Disease Quality of Life Myocardial Infarction 64

Open Heart

NOVEMBER 14, 2023

Previously, 80% of sudden cardiac arrest have been attributed to coronary artery disease. Survival curves were performed among hospitalised patients with acute myocardial infarction (AMI) as well as heart failure. Coronary artery disease is now likely in the minority with regard to causes of OHCA.

Cardiac Arrest 52

Cardiac Arrest Coronary Artery Disease Hospital Heart Failure 52

Circulation: Cardiovascular Interventions

NOVEMBER 28, 2023

The primary end point was target vessel failure defined as a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization.Results:At a median follow-up of 2.1 years (interquartile range 1.1 versus 25.1%; hazard ratio, 0.31 [95% CI, 0.13–0.76];P=0.010). 0.76];P=0.010).

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Disease Cardiovascular Interventions Circulation 40

All About Cardiovascular System and Disorders

APRIL 21, 2024

FAME study showed that at one year follow up, rate of major adverse coronary events was reduced by approximately 30% by routinely measuring FFR. They had lower rates of mortality or myocardial infarction. PCI or coronary artery bypass surgery rates were also lower, though not statistically significant.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Stents Stent 52